The future of COVID, and vaccine efficacy, is now dependent on variants, which experts predict could be on the rise plus become vaccine resistant. Read More
Tag: biogen
Dubious $56, 000 Alzheimer’s drug spurs largest Medicare price hike ever
Enlarge / Biogen Inc. headquarters in Cambridge, Massachusetts. Biogen Inc. shares soared after its controversial Alzheimer’s disease therapy was approved by US regulators. (credit: Getty | Bloomberg ) Seniors throughout the US will see a hefty increase to their health care premiums next year thanks in large part to Biogen’s Alzheimer’s drug, Aduhelm, which is […]
Medical boards are still struggling to discipline doctors who spread COVID-19 myths
The spread of medical misinformation by influential Americans are continuing to undermine trust in medicine and endanger the public. Read More
Medicare negotiating drug prices could be the game changer Americans need
Medicare’s lack of negotiating power is largely blamed for the sky-high drug prices that many Americans can’t afford. That could soon change, however, if Democrats’ new proposal for decreased drug pricing passes as part of President Biden’s Build Back Better Act. Read More
COVID vaccines could be the key to solving the global youth mental health emergency
Children around the world are suffering through an unprecedented mental health crisis, largely because they haven’t been able to attend school during the pandemic. Vaccines for children could be a pivotal first step to addressing the growing emergency. Read More
Why the FDA’s ruling on mixing and matching vaccines will help more people get boosters
The FDA permitting a mix-and-match vaccine booster approach increases access in three key ways: it allows people to get any booster that’s readily available to them, lets them choose which one they get, and reduces uncertainty about safety and efficacy. Read More
The stalemate over patents is fueling vaccine inequity—and the pandemic
Moderna’s refusal to share its vaccine recipe is the latest blow in a losing fight to ensure equitable vaccine access for all. Read More
Why Merck’s antiviral pill is not a silver bullet for COVID
Between the high cost and testing hurdles, molnupiravir may not be the “game changer” against COVID. Read More
Will vaccine mandates worsen the ongoing health care shortage?
More states are adopting vaccine mandates for health care workers, leaving the remaining unvaccinated, and hospitals already short staffed and filled with COVID patients, with limited options. Read More
The science behind a fond farewell
What motivation science has to say about goodbyes. Plus, GE’s $1.45 billion acquisition and monoclonal antibody bottleneck. Read More